Skip to main content
. 2021 Jun 2;70(9):2067–2080. doi: 10.2337/db20-1177

Figure 7.

Figure 7

Scheme representing how tolerogenic DCs sustain the DIO-resistant microbiota characterized by lower immunogenicity and enhanced butyrate production.